KuybyshevAzot PAO
MOEX:KAZT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
KuybyshevAzot PAO
MOEX:KAZT
|
RU |
|
Taikisha Ltd
TSE:1979
|
JP |
|
Happy Valley Nutrition Ltd
ASX:HVM
|
NZ |
|
I
|
Instadose Pharma Corp
OTC:INSD
|
US |
|
Ascentech KK
TSE:3565
|
JP |
|
Monex Group Inc
TSE:8698
|
JP |
|
Satyamitra Kemas Lestari Tbk PT
IDX:SMKL
|
ID |
|
Omaxe Ltd
NSE:OMAXE
|
IN |
|
ABM Industries Inc
NYSE:ABM
|
US |
|
Y
|
Yubico AB
STO:YUBICO
|
SE |
|
Cardiff Oncology Inc
NASDAQ:CRDF
|
US |
|
P
|
Pentamaster Corporation Bhd
KLSE:PENTA
|
MY |
|
Sastasundar Ventures Ltd
NSE:SASTASUNDR
|
IN |
|
U
|
UMediC Group Bhd
KLSE:UMC
|
MY |
|
K
|
Kmc Properties ASA
OSE:KMCP
|
NO |
Cash Flow Statement
Cash Flow Statement
KuybyshevAzot PAO
| Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Sep-2021 | Dec-2021 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||
| Net Income |
10 523
|
3 268
|
(256)
|
1 320
|
10 895
|
6 346
|
26 013
|
12 412
|
18 836
|
14 000
|
14 920
|
11 440
|
6 830
|
|
| Depreciation & Amortization |
3 057
|
3 414
|
3 416
|
3 333
|
3 482
|
2 967
|
4 063
|
1 895
|
4 472
|
5 249
|
5 660
|
8 049
|
9 812
|
|
| Other Non-Cash Items |
260
|
1 537
|
4 742
|
5 194
|
1 048
|
3 217
|
(790)
|
(3 351)
|
(2 953)
|
(715)
|
(7 679)
|
(6 626)
|
284
|
|
| Cash Taxes Paid |
0
|
948
|
274
|
460
|
1 513
|
1 431
|
3 817
|
3 191
|
6 228
|
4 259
|
1 672
|
1 716
|
1 462
|
|
| Cash Interest Paid |
1 747
|
1 763
|
1 732
|
1 497
|
1 205
|
979
|
1 117
|
415
|
930
|
1 048
|
1 093
|
2 870
|
4 395
|
|
| Change in Working Capital |
(2 881)
|
(5 674)
|
(2 300)
|
30
|
(4 885)
|
2 199
|
(3 487)
|
(8 180)
|
(12 637)
|
(8 904)
|
(3 550)
|
4 509
|
2 722
|
|
| Cash from Operating Activities |
10 959
N/A
|
2 545
-77%
|
5 602
+120%
|
9 877
+76%
|
10 540
+7%
|
14 602
+39%
|
25 799
+77%
|
2 776
-89%
|
7 718
+178%
|
9 630
+25%
|
9 351
-3%
|
17 372
+86%
|
19 648
+13%
|
|
| Investing Cash Flow | ||||||||||||||
| Capital Expenditures |
(10 015)
|
(3 869)
|
(1 192)
|
(6 306)
|
(3 506)
|
(4 336)
|
(3 997)
|
(3 484)
|
(6 516)
|
(6 723)
|
(9 504)
|
(9 672)
|
(7 250)
|
|
| Other Items |
166
|
(7 672)
|
(8 194)
|
952
|
1 295
|
(115)
|
(2 224)
|
(308)
|
(1 366)
|
(4 697)
|
8 959
|
13 435
|
434
|
|
| Cash from Investing Activities |
(9 849)
N/A
|
(11 541)
-17%
|
(9 386)
+19%
|
(5 354)
+43%
|
(2 211)
+59%
|
(4 450)
-101%
|
(6 221)
-40%
|
(3 792)
+39%
|
(7 882)
-108%
|
(11 420)
-45%
|
(545)
+95%
|
3 763
N/A
|
(6 816)
N/A
|
|
| Financing Cash Flow | ||||||||||||||
| Net Issuance of Common Stock |
(506)
|
1 597
|
734
|
0
|
0
|
(1 250)
|
(2 499)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
1 026
|
4 294
|
3 111
|
(2 299)
|
(4 965)
|
(4 923)
|
(5 057)
|
(3 620)
|
(6 429)
|
(4 362)
|
(6 749)
|
(9 537)
|
(19 490)
|
|
| Cash Paid for Dividends |
(1 233)
|
(1 069)
|
(360)
|
(230)
|
(1 281)
|
(119)
|
(1 332)
|
(5 977)
|
(8 352)
|
(4 907)
|
(3 758)
|
(1 688)
|
(1 144)
|
|
| Other |
1 763
|
1 196
|
(115)
|
(46)
|
(303)
|
0
|
(55)
|
(12)
|
(13)
|
(50)
|
(65)
|
(56)
|
(41)
|
|
| Cash from Financing Activities |
1 050
N/A
|
6 018
+473%
|
3 370
-44%
|
(2 575)
N/A
|
(6 549)
-154%
|
(6 539)
+0%
|
(8 943)
-37%
|
(9 609)
-7%
|
(14 794)
-54%
|
(9 319)
+37%
|
(10 572)
-13%
|
(11 281)
-7%
|
(20 675)
-83%
|
|
| Change in Cash | ||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
297
|
326
|
279
|
(4)
|
5 410
|
6 681
|
331
|
311
|
541
|
(961)
|
|
| Net Change in Cash |
2 160
N/A
|
(2 978)
N/A
|
(414)
+86%
|
2 245
N/A
|
2 106
-6%
|
3 892
+85%
|
10 631
+173%
|
(5 215)
N/A
|
(8 277)
-59%
|
(10 778)
-30%
|
(1 455)
+87%
|
10 395
N/A
|
(8 804)
N/A
|
|
| Free Cash Flow | ||||||||||||||
| Free Cash Flow |
944
N/A
|
(1 324)
N/A
|
4 410
N/A
|
3 571
-19%
|
7 034
+97%
|
10 266
+46%
|
21 802
+112%
|
(708)
N/A
|
1 202
N/A
|
2 907
+142%
|
(153)
N/A
|
7 700
N/A
|
12 398
+61%
|
|